PremiumUpdatedBusinessDesk24 Aug, 2026 06:22 AM5 mins to readChorus’ result was in line with market expectations but the company might struggle to lift prices as much as in the past because market conditions had become more competitive, an analyst said.Fisher & Paykel Healthcare hit a new high and Chorus fell after a solid annual result as the New Zealand sharemarket opened the week with a decline of more than 0.5%.
The S&P/NZX 50 Index broke through the 14,000 level at midday but was softer in the afternoon and closed
